Safety studies of the oral rabies vaccine SAD B19 in striped skunk (Mephitis mephitis).
Safety of the modified live rabies virus vaccine, SAD B19, was studied in striped skunks (Mephitis mephitis). Seven skunks received 10(7.9) foci formatting units by direct oral administration. In four cages, a vaccinated animal was placed with a control animal, the other three vaccinated skunks were housed individually. Saliva and nasal swabs were collected 1, 2, 4, 24, 48, and 72 hr post-vaccination. From all vaccinated and control animals (n = 11) blood samples were collected 0, 28, 56, 84, and 296 days post-vaccination. Three of seven vaccinated skunks seroconverted. None of the control animals had detectable levels of rabies virus neutralizing antibodies. Also no vaccine virus was isolated from the nasal and saliva swabs collected from any animal. Thus, SAD B19 was innocuous for skunks in our study after direct oral administration at field concentration.
Vos
A
A
Impfstoffwerk Dessau Tornau GmbH, PSF 214, 06855 Rosslau, Germany. ad.vos@idt-direct.de
Pommerening
E
E
Neubert
L
L
Kachel
S
S
Neubert
A
A
D000284:Administration, Oral; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D018562:Disease Transmission, Infectious / Q000662:veterinary; D005260:Female; D008297:Male; D012889:Mephitidae; D009297:Nasal Mucosa / Q000821:virology; D011818:Rabies / Q000517:prevention & control / Q000635:transmission / Q000662:veterinary*; D011819:Rabies Vaccines / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D011820:Rabies virus / Q000276:immunology / Q000302:isolation & purification; D012463:Saliva / Q000821:virology
D000914:Antibodies, Viral; D011819:Rabies Vaccines